M. I. Pérez Soto

High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study

P. Pérez-Martínez, J. Ena, J. M. Seguí-Ripoll, 2022, Journal of clinical medicine.

Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study.

J. Ena, R. Gómez-Huelgas, M. Folgueras, 2020, Revista clinica espanola.